19 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
and restated bylaws, procedures for our stockholder meetings, the classified board, director liability, and exclusive forum for proceedings.
Dividends. Subject
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
stockholder meetings, the classified board, director liability, and exclusive forum for proceedings.
Dividends. Subject to preferences that may
424B4
CGTX
Cognition Therapeutics Inc
8 Jan 24
Prospectus supplement with pricing info
4:11pm
, the classified board, director liability, and exclusive forum for proceedings.
Dividends. Subject to preferences that may be applicable to any
S-3
wl41xr m2dwn
23 Dec 22
Shelf registration
4:16pm
424B4
5wgvrq4mqtgrn1q
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
cwailrbbd0dhdyfax6y
20 Oct 22
Draft registration statement
12:00am
10-K
3gaydggnsxi
30 Mar 22
Annual report
7:40am
10-Q
n5nohkq 0c3m
17 Nov 21
Quarterly report
5:15pm
8-K
dlmir027j2nrwq6
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
tcz4y6 f3tnd8rgz1kp
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
8i3x57mfs
19 Jul 21
IPO registration
7:02am
DRS/A
ba3mz5rwivod2qck9r
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
20yq897z00aqz
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next